114 related articles for article (PubMed ID: 8986559)
1. [Influence of multiple-dose administration of cefetamet pivoxil on blood and urinary concentrations of carnitine and effects of simultaneous administration of carnitine with cefetamet pivoxil].
Nakashima M; Kosuge K; Ishii I; Ohtsubo M
Jpn J Antibiot; 1996 Oct; 49(10):966-79. PubMed ID: 8986559
[TBL] [Abstract][Full Text] [Related]
2. [Study of finding the optimum dose of cefetamet pivoxil in complicated urinary tract infections].
Ohmori H; Kumon H; Kanemasa Y; Hirai Y; Saito T
Jpn J Antibiot; 1990 Dec; 43(12):2102-32. PubMed ID: 2086824
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections].
Shimada J; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Deguchi K
Jpn J Antibiot; 1995 Jul; 48(7):949-59. PubMed ID: 7563588
[TBL] [Abstract][Full Text] [Related]
4. Cefetamet pivoxil clinical pharmacokinetics.
Blouin RA; Stoeckel K
Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
[TBL] [Abstract][Full Text] [Related]
5. Cefetamet pivoxil treatment causes loss of carnitine reserves that can be prevented by exogenous carnitine administration.
Pap M; Kopcsányi G; Bieber LL; Gage DA; Melegh B
J Nutr Biochem; 1999 Nov; 10(11):670-3. PubMed ID: 15539265
[TBL] [Abstract][Full Text] [Related]
6. Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.
Blouin RA; Kneer J; Ambros RJ; Stoeckel K
Antimicrob Agents Chemother; 1990 Sep; 34(9):1744-8. PubMed ID: 1981000
[TBL] [Abstract][Full Text] [Related]
7. Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil.
Brass EP; Mayer MD; Mulford DJ; Stickler TK; Hoppel CL
Clin Pharmacol Ther; 2003 Apr; 73(4):338-47. PubMed ID: 12709724
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.
Hayton WL; Kneer J; Blouin RA; Stoeckel K
Antimicrob Agents Chemother; 1990 Jul; 34(7):1318-22. PubMed ID: 2386364
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
Koup JR; Dubach UC; Brandt R; Wyss R; Stoeckel K
Antimicrob Agents Chemother; 1988 Apr; 32(4):573-9. PubMed ID: 3377466
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review.
Stoeckel K; Tam YK; Kneer J
Curr Med Res Opin; 1989; 11(7):432-41. PubMed ID: 2673663
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects.
Blouin RA; Kneer J; Stoeckel K
Antimicrob Agents Chemother; 1989 Mar; 33(3):291-6. PubMed ID: 2729925
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part II].
Shimada J; Ishihara R; Suzuki Y; Ishii Y; Nakazawa A; Deguchi K
Jpn J Antibiot; 1997 Sep; 50(9):756-67. PubMed ID: 9394236
[TBL] [Abstract][Full Text] [Related]
13. [Antimicrobial activities of cefetamet against clinical isolates from urinary tract infection].
Ishii Y; Suzuki Y; Ishihara R; Nakazawa A; Deguchi K
Jpn J Antibiot; 1996 Dec; 49(12):1073-84. PubMed ID: 9032594
[TBL] [Abstract][Full Text] [Related]
14. Cefetamet pivoxil in the treatment of pharyngotonsillitis due to group A beta-hemolytic streptococci: preliminary report.
Gervaix A; Brighi L; Halpérin DS; Suter S
J Chemother; 1995 May; 7 Suppl 1():21-4. PubMed ID: 8618109
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency.
Kneer J; Tam YK; Blouin RA; Frey FJ; Keller E; Stathakis C; Luginbuehl B; Stoeckel K
Antimicrob Agents Chemother; 1989 Nov; 33(11):1952-7. PubMed ID: 2610506
[TBL] [Abstract][Full Text] [Related]
16. [Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients].
Fujii R; Chiba S; Numazaki K; Mori T; Terashima I; Meguro H; Mori A; Toyonaga Y; Sunakawa K; Satoh Y
Jpn J Antibiot; 1993 Oct; 46(10):926-37. PubMed ID: 8254895
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children.
Hayton WL; Walstad RA; Thurmann-Nielsen E; Kufaas T; Kneer J; Ambros RJ; Rugstad HE; Monn E; Bodd E; Stoeckel K
Antimicrob Agents Chemother; 1991 Apr; 35(4):720-5. PubMed ID: 2069377
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers.
Tam YK; Kneer J; Dubach UC; Stoeckel K
Antimicrob Agents Chemother; 1989 Jun; 33(6):957-9. PubMed ID: 2764545
[TBL] [Abstract][Full Text] [Related]
19. Cefetamet pivoxil a new oral cephalosporin: clinical evaluation.
Kissling M; Germano G; Fernex M
Chemotherapy; 1988; 34(6):519-29. PubMed ID: 3243094
[TBL] [Abstract][Full Text] [Related]
20. Cefetamet pivoxil in otitis media.
Quevedo A; Sossouhounto R; Kissling M
ORL J Otorhinolaryngol Relat Spec; 1993; 55(2):93-6. PubMed ID: 8446394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
